EXCESS BRAIN PROTEIN OXIDATION AND ENZYME DYSFUNCTION IN NORMAL AGING AND IN ALZHEIMER-DISEASE

被引:1092
|
作者
SMITH, CD
CARNEY, JM
STARKEREED, PE
OLIVER, CN
STADTMAN, ER
FLOYD, RA
MARKESBERY, WR
机构
[1] UNIV KENTUCKY,MED CTR,SANDERS BROWN CTR AGING,LEXINGTON,KY 40536
[2] UNIV KENTUCKY,MED CTR,DEPT PHARMACOL,LEXINGTON,KY 40536
[3] GEORGE WASHINGTON UNIV,SCH MED,DEPT EXPTL MED,WASHINGTON,DC 20037
[4] MERCK & CO INC,RAHWAY,NJ 07065
[5] NHLBI,BIOCHEM LAB,BETHESDA,MD 20205
[6] OKLAHOMA MED RES FDN,MOLEC TOXICOL RES GRP,OKLAHOMA CITY,OK 73104
关键词
D O I
10.1073/pnas.88.23.10540
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The relationship between Alzheimer disease (AD) and aging is not currently known. In this study, postmortem frontal- and occipital-pole brain samples were obtained from 16 subjects with AD, 8 age-matched controls, and 5 young controls. These samples were analyzed both for protein oxidation products (carbonyl) and the activities of two enzymes vulnerable to mixed-function oxidation, glutamine synthetase and creatine kinase. Glutamine synthetase is more sensitive to mixed-function oxidation than creatine kinase. Carbonyl content rises exponentially with age, at double the rate in the frontal pole compared with the occipital pole. Compared with young controls, both aged groups (AD and age-matched controls) have increased carbonyl content and decreased glutamine synthetase and creatine kinase activities, which are more marked in the frontal than occipital pole in all instances. We conclude that protein oxidation products accumulate in the brain and that oxidation-vulnerable enzyme activities decrease with aging in the same regional pattern (frontal more affected than occipital). However, only glutamine synthetase activity distinguishes AD from age-matched controls: Because glutamine synthetase activity is differentially reduced in the frontal pole in AD, we suggest that AD may represent a specific brain vulnerability to age-related oxidation.
引用
收藏
页码:10540 / 10543
页数:4
相关论文
共 50 条
  • [1] THE HUMAN BRAIN MICROTUBULE SYSTEM IN NORMAL AGING AND ALZHEIMER-DISEASE
    JONES, CM
    WINGERT, TS
    WHITE, CL
    MCINTIRE, DD
    SPARKMAN, DR
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (03): : 316 - 316
  • [2] BRAIN ALUMINUM IN AGING AND ALZHEIMER-DISEASE
    MCDERMOTT, JR
    SMITH, AI
    IQBAL, K
    WISNIEWSKI, HM
    NEUROLOGY, 1979, 29 (06) : 809 - 814
  • [3] CHARACTERIZATION OF THE HUMAN BRAIN MICROTUBULE SYSTEM IN NORMAL AGING AND ALZHEIMER-DISEASE
    JONES, CM
    WINGERT, TS
    WHITE, CL
    MCINTIRE, DD
    SPARKMAN, DR
    FASEB JOURNAL, 1992, 6 (05): : A1917 - A1917
  • [4] Protein Oxidation in Aging and Alzheimer's Disease Brain
    Sultana, Rukhsana
    Butterfield, D. Allan
    ANTIOXIDANTS, 2024, 13 (05)
  • [5] SUBSTANTIA-NIGRA LESIONS IN ALZHEIMER-DISEASE AND NORMAL AGING
    KAZEE, AM
    COX, C
    RICHFIELD, EK
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1995, 9 (02): : 61 - 67
  • [6] AGING, ALZHEIMER-DISEASE, AND AMYLOID
    WAGNER, BM
    MODERN PATHOLOGY, 1990, 3 (06) : 641 - 642
  • [7] TRACE-ELEMENT CONTENT OF BRAIN IN ALZHEIMER-DISEASE AND AGING
    HERSHEY, CO
    HERSHEY, LA
    WONGMONGKOLRIT, T
    VARNES, AW
    BRESLAU, D
    TRACE ELEMENTS IN MEDICINE, 1985, 2 (01): : 40 - 43
  • [8] CHOLINERGIC RECEPTORS IN HUMAN BRAIN - EFFECTS OF AGING AND ALZHEIMER-DISEASE
    GIACOBINI, E
    JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 27 (04) : 548 - 560
  • [9] BRAIN AMYLOID AND ALZHEIMER-DISEASE
    VINTERS, HV
    MILLER, BL
    PARDRIDGE, WM
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (01) : 41 - 54
  • [10] RELATIVE ABUNDANCE OF ALZHEIMER A-BETA AMYLOID PEPTIDE VARIANTS IN ALZHEIMER-DISEASE AND NORMAL AGING
    NASLUND, J
    SCHIERHORN, A
    HELLMAN, U
    LANNFELT, L
    ROSES, AD
    TJERNBERG, LO
    SILBERRING, J
    GANDY, SE
    WINBLAD, B
    GREENGARD, P
    NORDSTEDT, C
    TERENIUS, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) : 8378 - 8382